...
首页> 外文期刊>Canadian journal of gastroenterology >Ulcerative colitis and Sweet's syndrome: a case report and review of the literature.
【24h】

Ulcerative colitis and Sweet's syndrome: a case report and review of the literature.

机译:溃疡性结肠炎和Sweet氏综合症:一例病例报告并文献复习。

获取原文
获取原文并翻译 | 示例
           

摘要

A 47-year-old man with a history of ulcerative colitis on prednisone and azathioprine was admitted to the hospital with a four-day history of fever, skin rash, arthralgias and leukocytosis. A skin biopsy demonstrated neutrophilic infiltration of the dermis that was consistent with Sweet's syndrome. He improved after several days with an increase in his prednisone and azathioprine. Sweet's syndrome is a rare cutaneous manifestation of inflammatory bowel disease, with approximately 40 cases reported in the literature. In a previously reported case of a patient with ulcerative colitis-associated Sweet's syndrome who was on azathioprine at the time of the skin eruption, the azathioprine was stopped, raising the possibility of drug-induced Sweet's syndrome. In the present case, the azathioprine was actually increased with complete resolution of the skin manifestations. This would support the theory that immunosuppressive therapy is the mainstay of therapy for this condition. In conclusion, Sweet's syndrome is a neutrophilic dermatosis that is rarely associated with ulcerative colitis. It may occur while on immunosuppressive therapy and responds to an intensification of immunosuppression.
机译:一名因泼尼松和硫唑嘌呤具有溃疡性结肠炎病史的47岁男子因四天发烧,皮疹,关节痛和白细胞增多病病史入院。皮肤活检显示真皮的嗜中性浸润与Sweet综合征一致。几天后,他的泼尼松和硫唑嘌呤增加,病情好转。甜氏综合症是炎症性肠病的一种罕见的皮肤表现,文献报道约有40例。在先前报道的患有溃疡性结肠炎相关性Sweet氏综合症的患者中,在皮肤萌发时使用硫唑嘌呤,该患者被停止使用硫唑嘌呤,从而增加了药物诱发的Sweet氏综合症的可能性。在本例中,硫唑嘌呤实际上随着皮肤表现的完全消退而增加。这将支持以下理论:免疫抑制疗法是该疾病的主要治疗手段。总之,Sweet's综合征是一种嗜中性皮肤病,很少与溃疡性结肠炎有关。它可能在进行免疫抑制治疗时发生,并对免疫抑制的加剧有反应。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号